Molecule engineering strategy of toll-like receptor 7/8 agonists designed for potentiating immune stimuli activation
Chemical Communications · 2024
DOI: 10.1039/d4cc00792a ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemical Communications, 2024. Verfasst von Liuwei Gu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Nantong Key Laboratory of Public Health and Medical Analysis, School of Public Health, Nantong University, No. 9, Seyuan Road, Nantong 226019, Jiangs…. Hauptthemen laut MEDLINE: Toll-Like Receptor 7, Toll-Like Receptor 8. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 97 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Excellent Youth Foundation of Jiangsu Scientific Committee.
Abstract (Originalsprache)
We highlighted the recent research progress concerning the molecule engineering strategy of toll-like receptor 7/8 agonists for enhancing immunotherapy, including our research work and some related emerging works.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Nantong Key Laboratory of Public Health and Medical Analysis, School of Public Health, Nantong University, No. 9, Seyuan Road, Nantong 226019, Jiangsu, P. R. China. gli@ntu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Excellent Youth Foundation of Jiangsu Scientific Committee
Zitieren
APA
Gu, L., Kong, X., Li, M., Chen, R., Xu, K., Li, G., Qin, Y., & Wu, L. (2024). Molecule engineering strategy of toll-like receptor 7/8 agonists designed for potentiating immune stimuli activation. Chemical Communications. https://doi.org/10.1039/d4cc00792a
Vancouver
Gu L, Kong X, Li M, Chen R, Xu K, Li G, et al. Molecule engineering strategy of toll-like receptor 7/8 agonists designed for potentiating immune stimuli activation. Chemical Communications. 2024. doi:10.1039/d4cc00792a
BibTeX
@article{Gu2024,
author = {Gu, Liuwei and Kong, Xiaojie and Li, Mengyan and Chen, Rui and Xu, Ke and Li, Guo and Qin, Yulin and Wu, Li},
title = {Molecule engineering strategy of toll-like receptor 7/8 agonists designed for potentiating immune stimuli activation},
journal = {Chemical Communications},
year = {2024},
doi = {10.1039/d4cc00792a}
}
EUVIMED